Botanix Pharmaceuticals Limited

OTCPK:BXPH.F Stock Report

Market Cap: US$475.5m

Botanix Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BXPH.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Apr 25BuyUS$4,464,353UniSuper Management Pty LtdCompany36,333,941US$0.27
24 Apr 25BuyUS$986,763IOOF Investment Management LimitedCompany3,339,583US$0.31
19 Apr 25SellUS$762,462IOOF Investment Management LimitedCompany4,469,401US$0.25
14 Apr 25SellUS$4,505,254MLC Investments LimitedCompany15,340,743US$0.29
24 Mar 25BuyUS$712,707MLC Investments LimitedCompany2,616,522US$0.27
21 Mar 25BuyUS$1,618,899OnePath Funds Management LimitedCompany5,735,488US$0.28
21 Feb 25SellUS$257,501UniSuper Management Pty LtdCompany774,352US$0.33
15 Jan 25SellUS$1,040,125Vincent IppolitoIndividual3,800,000US$0.27
09 Jan 25SellUS$1,330,777IOOF Investment Management LimitedCompany8,512,636US$0.16
06 Jan 25BuyUS$362,603IOOF Investment Management LimitedCompany1,628,900US$0.23
06 Dec 24BuyUS$125,102Antares Capital Partners LimitedCompany598,561US$0.21
27 Nov 24SellUS$125,014Antares Capital Partners LimitedCompany568,320US$0.22
21 Nov 24BuyUS$27,408MLC Investments LimitedCompany67,712US$0.40
16 Sep 24SellUS$2,685,446MLC Investments LimitedCompany10,273,752US$0.26
28 Jun 24BuyUS$1,973,734Antares Capital Partners LimitedCompany15,573,589US$0.13
28 Jun 24BuyUS$6,959,100MLC Investments LimitedCompany43,646,867US$0.16
28 Jun 24BuyUS$10,890,279IOOF Investment Management LimitedCompany65,551,485US$0.24
12 Jun 24SellUS$1,713,267IOOF Investment Management LimitedCompany12,278,755US$0.14

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BXPH.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies22,272,2221.14%
Private Companies38,474,8491.97%
Individual Insiders182,774,4849.35%
Institutions507,914,30426%
General Public1,202,504,60461.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24%.

Top Shareholders

Top 25 shareholders own 38.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
IOOF Investment Management Limited
207,136,620US$50.4m289%2.31%
5.68%
MLC Investments Limited
110,978,010US$27.0m1.33%8.75%
5.14%
UniSuper Management Pty Ltd
100,455,466US$24.4m0%0.17%
3.82%
Matthew Callahan
74,586,791US$18.2m0%no data
2.69%
Gayle McGarry
52,573,874US$12.8m0%no data
1.39%
The Vanguard Group, Inc.
27,251,615US$6.6m0%no data
1.25%
Antares Capital Partners Limited
24,386,669US$5.9m0.12%13.03%
1.14%
Zenith Energy Ltd.
22,272,222US$5.4m0%no data
0.96%
Henry Bosch
18,836,702US$4.6m0%no data
0.78%
Yarraandoo Pty Ltd
15,166,667US$3.7m0%no data
0.77%
Vincent Ippolito
15,001,644US$3.7m38.9%no data
0.63%
Matthew Moffatt Family Trust
12,378,182US$3.0m0%no data
0.62%
Wilson Asset Management (International) Pty Ltd.
12,166,731US$3.0m0%0.1%
0.56%
Rollo Corp Property Holdings Pty Ltd
10,930,000US$2.7m0%no data
0.42%
Netwealth Investments Ltd.
8,277,790US$2.0m0%0.02%
0.4%
Nicolas Fayd'herbe
7,888,032US$1.9m0%no data
0.34%
Allianz Asset Management GmbH
6,638,897US$1.6m0%no data
0.29%
OnePath Funds Management Limited
5,735,488US$1.4m0%0.93%
0.27%
Daniel Sharp
5,242,458US$1.3m146%no data
0.24%
Stewart Washer
4,644,983US$1.1m114%no data
0.2%
Howie McKibbon
4,000,000US$973.5k0%no data
0.061%
Davy Global Fund Management Limited
1,191,969US$290.1k0%0.14%
0.043%
BlackRock, Inc.
832,031US$202.5k0%no data
0.041%
Fideuram Asset Management (Ireland) DAC
800,201US$194.7k0%no data
0.04%
Dimensional Fund Advisors LP
784,836US$191.0k0.04%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 22:46
End of Day Share Price 2025/05/13 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Botanix Pharmaceuticals Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter